Mabion
  • Company
    • About us
      • History
      • Leaderships
      • Team
      • EU grants
      • Requests for Proposal
      • Sustainability – ESG
      • Bussines strategy
      • Quality policy
      • Virtual Tour
    • Investors
      • Corporate documents
      • Shareholders and shares
      • Periodic reports
      • Current reports
      • Sustainability reports
      • Corporate governance at Mabion
      • Financial data
      • For Investors
      • Calendar
  • Resources
    • Science Hub
    • Press releases
    • News
    • Events
    • Media kit
  • Services
    • Process Development
    • Analytics 
    • Drug Substance Manufacturing
  • Contact
    • Contact form
    • Contact for investors
    • Contact for media
    • Careers
  • Science News
  • Resources

Drug development

Popular receptor targets for oncologic bispecific antibodies

Oncologic Bispecific Antibodies in Immunotherapy

Biologics, Bispecific antibody, Cancer, Drug development
bioprocess optimization

Bioprocess Optimization Across Upstream and Downstream Processing

Drug development, Drug product, Drug substance, Manufacturing
cell line development

Tailoring Cell Line Development for Efficient Biologics Process Outcomes

Biologics, Drug development, GMP, Manufacturing
ADC development

Challenges and Solutions in ADC Development for Biologic Therapeutics

Antibody-drug conjugates, Biologics, Drug development
gmp biologics manufacturing

GMP Biologics Manufacturing in End-to-End Drug Development

Biologics, Drug development, GMP, Manufacturing
Biggest Analytical Challenges in Biosimilar Characterization and Comparability

5 Analytical Challenges in Biosimilar Characterization and Comparability

Biologics, Drug development
Integrated modeling of upstream and downstream bioprocessing to improve biologics production efficiency

Poster

Integrated Modeling of Upstream and Downstream Bioprocessing to Improve Biologics Production Efficiency

Biologics, Drug development, Mabion, Manufacturing
automatic assay HTS

The Role of High-Throughput Screening (HTS) in Cell Line Development and Process Optimization

Biologics, Drug development
Co-Development Partnership Models in Biologics Programs

Co-Development Partnership Models in Biologics Programs

Biologics, Drug development, Mabion, Partnership
1 2 3 Next

Contact

Find out how we may support your business.

bd@mabion.eu

Mabion

gen. Mariana Langiewicza 60
95-050 Konstantynów Łódzki
Poland

+48 42 207 78 90

    Mabion
    • Privacy policy
    • CDMO
    • Media kit
    • Press releases
    • Events

    This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply. HTML Sitemap

    Powered by

    Veneo